| Mrs Candace C Waters, MSN, FNP-BC, CDE | |
|
124 Bettis Academy Rd, Graniteville, SC 29829-3107 | |
| (803) 392-3724 | |
| (803) 234-5593 |
| Full Name | Mrs Candace C Waters |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner |
| Experience | 29 Years |
| Location | 124 Bettis Academy Rd, Graniteville, South Carolina |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1962496554 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363LF0000X | Nurse Practitioner - Family | 459 (South Carolina) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Aiken Professional Association Llc | 0446430805 | 46 |
News Archive
A new study has found why a mutation in a particular gene can lead to obesity. Mouse experiments suggested the body's message to "stop eating" was blocked if the animals had the mutation. The study, published in Nature Medicine, said the brain's response to appetite hormones was being disrupted.
Cranberries are more than a holiday favorite, given their remarkable nutritional and health benefits. A new research review published in the international journal Advances in Nutrition provides reasons why these tiny berries can be front and center and not just a side dish. The review authors conclude that cranberries provide unique bioactive compounds that may help reduce the incidence of certain infections, improve heart health and temper inflammation.
Doctors at the Peter Munk Cardiac Centre today performed a minimally invasive surgical procedure to treat high blood pressure, called renal denervation, for the first time in Canada.
A leading UK fertility expert is warning that infertility is set to double in Europe over the next decade and could threaten Europe's population.
Pfizer Inc. announced today that two Phase 3 studies of Sutent® (sunitinib malate) in advanced breast cancer did not meet their primary endpoints. The SUN 1064 Phase 3 study of sunitinib in combination with docetaxel for the first-line treatment of patients with advanced HER-2 negative breast cancer did not show a statistically significant improvement in progression-free survival compared with docetaxel alone.
› Verified 2 days ago
| Entity Name | Aiken Professional Association Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1639479801 PECOS PAC ID: 0446430805 Enrollment ID: O20110202000685 |
News Archive
A new study has found why a mutation in a particular gene can lead to obesity. Mouse experiments suggested the body's message to "stop eating" was blocked if the animals had the mutation. The study, published in Nature Medicine, said the brain's response to appetite hormones was being disrupted.
Cranberries are more than a holiday favorite, given their remarkable nutritional and health benefits. A new research review published in the international journal Advances in Nutrition provides reasons why these tiny berries can be front and center and not just a side dish. The review authors conclude that cranberries provide unique bioactive compounds that may help reduce the incidence of certain infections, improve heart health and temper inflammation.
Doctors at the Peter Munk Cardiac Centre today performed a minimally invasive surgical procedure to treat high blood pressure, called renal denervation, for the first time in Canada.
A leading UK fertility expert is warning that infertility is set to double in Europe over the next decade and could threaten Europe's population.
Pfizer Inc. announced today that two Phase 3 studies of Sutent® (sunitinib malate) in advanced breast cancer did not meet their primary endpoints. The SUN 1064 Phase 3 study of sunitinib in combination with docetaxel for the first-line treatment of patients with advanced HER-2 negative breast cancer did not show a statistically significant improvement in progression-free survival compared with docetaxel alone.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Candace C Waters, MSN, FNP-BC, CDE 367 S. Gulph Rd, Att: Ipm Credentialing, King Of Prussia, PA 19406-3121 Ph: (803) 392-3724 | Mrs Candace C Waters, MSN, FNP-BC, CDE 124 Bettis Academy Rd, Graniteville, SC 29829-3107 Ph: (803) 392-3724 |
News Archive
A new study has found why a mutation in a particular gene can lead to obesity. Mouse experiments suggested the body's message to "stop eating" was blocked if the animals had the mutation. The study, published in Nature Medicine, said the brain's response to appetite hormones was being disrupted.
Cranberries are more than a holiday favorite, given their remarkable nutritional and health benefits. A new research review published in the international journal Advances in Nutrition provides reasons why these tiny berries can be front and center and not just a side dish. The review authors conclude that cranberries provide unique bioactive compounds that may help reduce the incidence of certain infections, improve heart health and temper inflammation.
Doctors at the Peter Munk Cardiac Centre today performed a minimally invasive surgical procedure to treat high blood pressure, called renal denervation, for the first time in Canada.
A leading UK fertility expert is warning that infertility is set to double in Europe over the next decade and could threaten Europe's population.
Pfizer Inc. announced today that two Phase 3 studies of Sutent® (sunitinib malate) in advanced breast cancer did not meet their primary endpoints. The SUN 1064 Phase 3 study of sunitinib in combination with docetaxel for the first-line treatment of patients with advanced HER-2 negative breast cancer did not show a statistically significant improvement in progression-free survival compared with docetaxel alone.
› Verified 2 days ago
Robin Theo Mitchell, FNP-BC Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 110 Sasanqua Dr, Graniteville, SC 29829 Phone: 803-392-1811 Fax: 803-761-6247 |